Ethan Shen PhD - 30 Sep 2025 SCHEDULE 13G Report for YD Bio Ltd Ordinary Shares, par value of US$0.0001 per share (YDES)

Filing Manager: Ethan Shen PhD
Reporting Manager: Ethan Shen
Security: YD Bio Ltd Ordinary Shares, par value of US$0.0001 per share
Symbol: YDES
Shares outstanding: 70,486,396 shares
Disclosed Ownership: 54,345,011 shares
Ownership: 77%
Form type: SCHEDULE 13G
Filing time: 16 Dec 2025, 21:58:08 UTC
Date of event: 30 Sep 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ethan Shen	77%	54,345,011	54,345,011	0	/s/ Ethan Shen	Ethan Shen
YD Biopharma Holding Limited	61%	43,120,858	43,120,858	0	/s/ Ethan Shen	Director
EG Biomed Limited	16%	11,224,153	11,224,153	0	/s/ Ethan Shen	Director